Skip to content

RHEUMATOID ARTHRITIS TREATMENT IN HOMOEOPATHY

EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN COMPARISON WITH CURCUMA LONGA TINCTURE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: AN OPEN RANDOMIZED CLINICAL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053582
Enrollment
60
Registered
2023-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Administration of Curcuma longa tincture and individualised Homoeopathic medicines.: After screening of patients on the basis of inclusion and exclusion criteria, those patients who ful

Sponsors

F.LALCHHANHIMI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases with a score more than or equal to 6 as per ACR/EULAR 2010 criteria, patients with the moderate and severe activity of DAS28 score, persons aged 20 to 65 years, patients not under any conventional treatment except those on occasional painkillers, controlled cases of diabetes, hypertension, hyper or hypothyroidism, patients with written informed consent

Exclusion criteria

Exclusion criteria: Patients in a terminal stage of disease will be treated but not included in the study, patients having other joint affection or arthritis, patient with other coexisting active disease which is not controlled, pregnant and lactating women will be excluded in the study, patient unwilling to take part and not giving consent, patients who are already taking homoeopathic medicine for any chronic illness, patients who are suffering from any life threatening or immunocompromised state.

Design outcomes

Primary

MeasureTime frame
ACR/EULAR CRITERIA 2010Timepoint: Baseline data obtained will be compared with the data obtained after 3 months and after 6 months of treatment.

Secondary

MeasureTime frame
WHOQOL BREF QUESTIONNAIRETimepoint: Baseline data obtained will be compared with the data obtained after 3 months and after 6 months of treatment.

Countries

India

Contacts

Public ContactMOHIT MATHUR

NEHRU HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

drmohitmathur@gmail.com9818449588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026